Cure IBM Research Fund at TMA
Forecasted
The Cure IBM Research Fund at TMA supports foundational research into the biological and mechanistic causes of inclusion body myositis, funded by The Myositis Association.
Browse similar grants
Funder: The Myositis Association
Due Dates (Anticipated): May 2027 (Letter of intent, projected) | July 2027 (Full application, projected)
Funding Amounts: Up to $105,000 per award; 12–24 month project period; includes travel support for conferences.
Summary: Supports basic science and mechanistic research to advance understanding of the causes and progression of inclusion body myositis (IBM).
Description
The Cure IBM Research Fund at TMA is a grant program of The Myositis Association designed to accelerate foundational research into the biological mechanisms of inclusion body myositis (IBM). This initiative supports hypothesis-driven studies focused on the early molecular and cellular changes in muscle fibers, and the mechanisms underlying inflammation and degeneration in IBM. Priority topics include RNA processing defects, mitochondrial dysfunction, immune response mechanisms, stromal remodeling, and intercellular signaling. The grant seeks to generate crucial insights and preliminary data that can inform future research and therapeutic strategies for IBM.
